Litcius/Paper detail

Therapeutic options for mucinous ovarian carcinoma

Kylie L. Gorringe, Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland, Prue E. Allan, Kathryn Alsop, Kaushalya Amarasinghe, Sumitra Ananda, David D.L. Bowtell, Michael Christie, Yoke-Eng Chiew, Michael Churchman, Anna DeFazio, Sián Fereday, C. Blake Gilks, Charlie Gourley, Alison Hadley, Joy Hendley, Sally M. Hunter, Scott H. Kaufmann, Catherine J. Kennedy, Martin Köbel, Cécile Le Page, Jason Li, Richard Lupat, Orla McNally, Jessica N. McAlpine, Jan Pyman, Simone M. Rowley, Carolina Salazar, Hugo Saunders, Timothy Semple, Andrew N. Stephens, Niko Thio, Michelle C. Torres, Nadia Traficante, Magnus Zethoven, Yoland Antill, Ian Campbell, Clare L. Scott

2020Gynecologic Oncology94 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMucinous carcinomaOvarian carcinomaOncologyCarcinomaOvaryInternal medicineGeneral surgeryGynecologyOvarian cancerAdenocarcinomaCancerOvarian cancer diagnosis and treatmentPARP inhibition in cancer therapyBRCA gene mutations in cancer